AR118580A1 - Formulación de tableta vaginal - Google Patents
Formulación de tableta vaginalInfo
- Publication number
- AR118580A1 AR118580A1 ARP200100936A ARP200100936A AR118580A1 AR 118580 A1 AR118580 A1 AR 118580A1 AR P200100936 A ARP200100936 A AR P200100936A AR P200100936 A ARP200100936 A AR P200100936A AR 118580 A1 AR118580 A1 AR 118580A1
- Authority
- AR
- Argentina
- Prior art keywords
- pharmaceutical composition
- tablet formulation
- vaginal tablet
- vaginal
- glucono
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000000003 vaginal tablet Substances 0.000 title 1
- 229940044977 vaginal tablet Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 5
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 abstract 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 abstract 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 abstract 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 abstract 1
- 229960003943 hypromellose Drugs 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000000813 microbial effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente se refiere a una composición farmacéutica que comprende glucono d-lactona, que es adecuada para uso en el tratamiento de infecciones microbianas vaginales. Reivindicación 1: Una composición farmacéutica adecuada para administración vaginal, en donde la composición farmacéutica comprende a) de 5 a 30% p/p de Glucono d-lactona (GDL); y b) de 10 a 40% p/p de Hipromelosa (HPMC). Reivindicación 2: La composición farmacéutica de acuerdo con la reivindicación 1, en donde la composición farmacéutica es una tableta.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19167495 | 2019-04-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR118580A1 true AR118580A1 (es) | 2021-10-20 |
Family
ID=66101895
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP200100936A AR118580A1 (es) | 2019-04-05 | 2020-04-03 | Formulación de tableta vaginal |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US12496288B2 (es) |
| EP (1) | EP3976000B1 (es) |
| JP (1) | JP7610847B2 (es) |
| KR (1) | KR102900830B1 (es) |
| CN (1) | CN113660928B (es) |
| AR (1) | AR118580A1 (es) |
| AU (1) | AU2020252268B2 (es) |
| BR (1) | BR112021019999A2 (es) |
| CA (1) | CA3134086A1 (es) |
| CL (1) | CL2021002430A1 (es) |
| CO (1) | CO2021014253A2 (es) |
| EA (1) | EA202192716A1 (es) |
| ES (1) | ES2961736T3 (es) |
| HU (1) | HUE062772T2 (es) |
| IL (1) | IL286942B2 (es) |
| MA (1) | MA56011A (es) |
| MX (1) | MX2021012146A (es) |
| MY (1) | MY208388A (es) |
| PE (1) | PE20220381A1 (es) |
| PH (1) | PH12021552462A1 (es) |
| PL (1) | PL3976000T3 (es) |
| SG (1) | SG11202110236QA (es) |
| TW (1) | TWI846854B (es) |
| UA (1) | UA127823C2 (es) |
| WO (1) | WO2020201515A1 (es) |
| ZA (1) | ZA202106877B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2018346361B2 (en) | 2017-10-06 | 2024-07-25 | Gedea Biotech Ab | Gluconic acid derivatives for use in the treatment and/or prevention of microbial infections |
| WO2024261110A1 (en) * | 2023-06-22 | 2024-12-26 | Gedea Biotech Ab | Compositions for promoting growth of lactobacillus crispatus |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR245888A1 (es) * | 1989-01-23 | 1994-03-30 | Merrell Pharma Inc | Procedimiento para la preparacion de una composicion farmaceutica liquida de derivados de piperidinoalcanol. |
| FR2710265B1 (fr) * | 1993-09-22 | 1995-10-20 | Adir | Composition pharmaceutique bioadhésive pour la libération contrôlée de principes actifs. |
| US6248358B1 (en) * | 1998-08-25 | 2001-06-19 | Columbia Laboratories, Inc. | Bioadhesive progressive hydration tablets and methods of making and using the same |
| DE69802260T2 (de) * | 1998-04-30 | 2002-07-04 | Renata Maria Anna Cavaliere Vesely | Pharmazeutische Zusammensetzungen enthaltend Lactobacillus brevis und Lactobacillus salivarius zur Behandlung von Vaginainfektionen |
| US6287599B1 (en) * | 2000-12-20 | 2001-09-11 | Shire Laboratories, Inc. | Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles |
| US20030017207A1 (en) | 2001-05-01 | 2003-01-23 | Lin Shun Y. | Compositions and methods for treating vulvovaginitis and vaginosis |
| BR0215707A (pt) * | 2002-04-23 | 2005-05-03 | Lupin Ltd | Composição farmacêutica para a liberação controlada de ingredientes ativos e processo para a preparação de uma composição farmacêutica |
| EP1567131A1 (en) * | 2002-11-15 | 2005-08-31 | Ranbaxy Laboratories, Ltd. | Bupropion hydrochloride solid dosage forms |
| EP1872775A1 (en) * | 2006-06-29 | 2008-01-02 | Polichem S.A. | Use of a hydrophilic matrix comprising a polyacrylic acid derivative, a cellulose ether and a disintegrant for the manufacture of a medicament for treating female genital disorders |
| ITBO20110461A1 (it) * | 2011-07-29 | 2013-01-30 | Alfa Wassermann Spa | Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali. |
| CN109069413B (zh) * | 2016-04-06 | 2022-09-27 | 盖迪亚生物技术公司 | 用于治疗阴道真菌感染的葡萄糖酸δ-内酯 |
| AU2018346361B2 (en) | 2017-10-06 | 2024-07-25 | Gedea Biotech Ab | Gluconic acid derivatives for use in the treatment and/or prevention of microbial infections |
-
2020
- 2020-04-03 AR ARP200100936A patent/AR118580A1/es unknown
- 2020-04-03 ES ES20715885T patent/ES2961736T3/es active Active
- 2020-04-03 PL PL20715885.8T patent/PL3976000T3/pl unknown
- 2020-04-03 BR BR112021019999A patent/BR112021019999A2/pt unknown
- 2020-04-03 US US17/601,521 patent/US12496288B2/en active Active
- 2020-04-03 IL IL286942A patent/IL286942B2/en unknown
- 2020-04-03 JP JP2021560220A patent/JP7610847B2/ja active Active
- 2020-04-03 PE PE2021001545A patent/PE20220381A1/es unknown
- 2020-04-03 CA CA3134086A patent/CA3134086A1/en active Pending
- 2020-04-03 EA EA202192716A patent/EA202192716A1/ru unknown
- 2020-04-03 KR KR1020217033774A patent/KR102900830B1/ko active Active
- 2020-04-03 MA MA056011A patent/MA56011A/fr unknown
- 2020-04-03 PH PH1/2021/552462A patent/PH12021552462A1/en unknown
- 2020-04-03 EP EP20715885.8A patent/EP3976000B1/en active Active
- 2020-04-03 SG SG11202110236QA patent/SG11202110236QA/en unknown
- 2020-04-03 MY MYPI2021005940A patent/MY208388A/en unknown
- 2020-04-03 UA UAA202106160A patent/UA127823C2/uk unknown
- 2020-04-03 HU HUE20715885A patent/HUE062772T2/hu unknown
- 2020-04-03 WO PCT/EP2020/059582 patent/WO2020201515A1/en not_active Ceased
- 2020-04-03 CN CN202080027260.1A patent/CN113660928B/zh active Active
- 2020-04-03 MX MX2021012146A patent/MX2021012146A/es unknown
- 2020-04-03 AU AU2020252268A patent/AU2020252268B2/en active Active
- 2020-04-06 TW TW109111529A patent/TWI846854B/zh active
-
2021
- 2021-09-17 ZA ZA2021/06877A patent/ZA202106877B/en unknown
- 2021-09-20 CL CL2021002430A patent/CL2021002430A1/es unknown
- 2021-10-25 CO CONC2021/0014253A patent/CO2021014253A2/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20210401A1 (es) | Composiciones farmaceuticas que comprenden meloxicam | |
| UY37952A (es) | Formulaciones de un inhibidor de la quinasa trk macrocíclica | |
| CL2020002252A1 (es) | Formulación oftálmica. | |
| CL2016001411A1 (es) | Unidad de dosificación farmacéutica solida de desintegración oral que comprende un componente de estetrol; metodo de preparación; uso para la anticoncepción femenina y en terápia de sustitución hormonal femenina. | |
| CY1109910T1 (el) | Χρηση μιας υδροφιλης μητρας η οποια περιεχει ενα παραγωγο πολυακρυλικου οξεος, εναν αιθερα κυτταρινης και εναν παραγοντα αποσαθρωσης για την παραγωγη ενος φαρμακου για την αγωγη ασθενειων των γυναικειων γεννητικων οργανων | |
| MX2019012757A (es) | Composicion farmaceutica para administracion oral que comprende enzalutamida. | |
| AR115913A1 (es) | Formas de dosificación oral biodisponibles, uso, métodos | |
| AR118580A1 (es) | Formulación de tableta vaginal | |
| MX2019015927A (es) | Composiciones para administración de fármacos y métodos de uso de las mismas. | |
| CO2023005726A2 (es) | Formulación sólida | |
| CY1125075T1 (el) | Εκχυλισμα salvia haenkei σαν δραστικος παραγοντας στις διαδικασιες επανεπιθηλιωσης και επουλωσης ιστων | |
| TR201904382T4 (tr) | Vajinit tedavisi. | |
| CL2018002705A1 (es) | Glucono delta-lactona para el tratamiento de infecciones fúngicas vaginales | |
| MX362717B (es) | Formulaciones de agomelatina que comprenden agomelatina en forma de cocristales. | |
| CL2022003426A1 (es) | Composición farmacéutica acuosa de levilimab y su uso | |
| BR112021026471A2 (pt) | Formulações de dose sólida para a liberação sem agulha | |
| CO2018001531A2 (es) | Lisobactina para su uso en el tratamiento de la mastitis bovina | |
| CO2025003585A2 (es) | Formulación líquida de belumosudil | |
| PL422140A1 (pl) | Zastosowanie totarolu i kompozycja farmaceutyczna zawierająca totarol | |
| NZ742220A (en) | Pharmaceutical compositions comprising meloxicam | |
| ZA202311560B (en) | Immediate release fixed-dose combination of memantine and donepezil | |
| PE20242349A1 (es) | Composicion en espray nasal bioadhesivo, proceso de preparacion y uso | |
| CL2023001196A1 (es) | Composición farmacéutica adecuada para administración vaginal en forma de óvulos y uso de la misma. | |
| MX2021000950A (es) | Composiciones que comprenden un extracto de arandano americano y fosfolipidos. | |
| UA130743U (uk) | Фармацевтична композиція антидіабетичної дії у формі матричних таблеток |